14 October, 2018

08:30 to 10:30UTC+02:00

Risk-based investments in regulatory systems: A global call to action

Room Ehrlich, Park Inn by Radisson Berlin Alexanderplatz Hotel, Alexanderplatz 7, Berlin 10178 Germany

IFPMA is proud to be co-hosting the event together with US Pharmacopeia, Bill & Melinda Gates Foundation and London School of Hygiene and Tropical Medicine.

Ensuring patient access to quality-assured medicines in support of achieving universal health coverage, decreasing antimicrobial resistance and combatting diseases such as TB, HIV, and malaria

One third of the world’s population lacks sustainable and timely access to quality-assured medicine. This global problem undermines the treatment of diseases such as tuberculosis, malaria, and HIV/AIDS, and contributes to antimicrobial resistance (AMR), with the greatest risk in low- and middle-income countries. In collaboration with NRAs, donors, multilateral organizations, non-governmental entities, academia, and the private sector, the United States Pharmacopeia (USP) recently published a peer-reviewed journal article, identifying investment priorities for sustainably strengthening medical product regulatory systems over the next decade.

Please join us for a cross-sector panel discussion convened by USP to discuss the challenges and opportunities to strengthen systems and ensure access to quality medicines. Breakfast and registration will begin at 8:30 a.m.

RSVP